Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | SOS1 | Q07889 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9971924 | 1.00 | HPRT1 (0.45) | HPRT1ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL26053248 | 0.98 | HPRT1 (0.44) | HPRT1ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL26053365 | 0.98 | HPRT1 (0.44) | HPRT1ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL26053270 | 0.97 | HPRT1 (0.45) | HPRT1ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL9971789 | 0.97 | HPRT1 (0.45) | HPRT1ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL26053246 | 0.94 | HPRT1 (0.40) | HPRT1ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL26053299 | 0.94 | HPRT1 (0.40) | HPRT1ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL9888987 | 0.93 | HPRT1 (0.52) | HPRT1ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL26053748 | 0.93 | HPRT1 (0.39) | HPRT1ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL26053273 | 0.93 | HPRT1 (0.39) | HPRT1ALDH1A1HSD17B10CYP2A6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120153815-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20110175521-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110175521-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | HPRT1 2868/4885ALDH1A1 2388/4885HSD17B10 2146/4885 |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | HPRT1 2868/4885ALDH1A1 2388/4885HSD17B10 2146/4885 |
| US-20120153815-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | ARL1, RIF1, EML4 | HPRT1 1563/4885ALDH1A1 699/4885HSD17B10 3421/4885 |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | HPRT1 2868/4885ALDH1A1 2388/4885HSD17B10 2146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.